The Saudi Arabia Diabetes Drug Market size was valued at around USD 2 billion in 2024 and is projected to reach USD 3.4 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period (2025-30).       

Saudi Arabia Diabetes Drug Market Driver:

High Prevalence of Diabetes Propelling Market Growth – Due to genetic predispositions and unhealthy lifestyle choices, Saudi Arabia has one of the highest prevalence rates in the world. By 2026, around 24% of the total adult population of Saudi Arabia is expected to have Diabetes which was just around 17.7% in 2021. This rising prevalence is leading the nation to become the 2nd highest in the Middle East and 7th highest globally in diabetes occupancy. An unhealthy lifestyle has resulted in the prevalence of obesity-related problems in Saudi Arabia that majorly pose a threat to several chronic diseases like Type-2 diabetes. An approximate 35.4% of the adult population of Saudi Arabia suffers from obesity. This creates an immense nationwide demand for Diabetes Drugs for the treatment and prevention of diabetes, thereby significantly contributing to the market growth.

Another reason is the country has some of the highest per capita consumption of sugar-filled drinks which worsens the diabetes epidemic. High prevalence rates of the disease result from this sort of sedentary behavior allied with diets full of fat and sugar which fuels the growth of the Saudi Arabia Diabetes Drug Market.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/saudi-arabia-diabetes-drug-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/saudi-arabia-diabetes-drug-market.html

Saudi Arabia Diabetes Drug Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

• By Insulins
  • Basal- Market Size & Forecast 2020-2030, USD Million
    • Lantus (Insulin Glargine)- Market Size & Forecast 2020-2030, USD Million
    • Levemir (Insulin Detemir)- Market Size & Forecast 2020-2030, USD Million
    • Toujeo(Insulin Glargine)- Market Size & Forecast 2020-2030, USD Million
    • Tresiba(Insulin Degludec)- Market Size & Forecast 2020-2030, USD Million
    • Basaglar (Insulin Glargine) - Market Size & Forecast 2020-2030, USD Million
  • Bolous- Market Size & Forecast 2020-2030, USD Million
    • NovoRapid/Novolog (Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million
    • Humalog (Insulin Lispro)- Market Size & Forecast 2020-2030, USD Million
    • Apidra (Insulin Glulisine)- Market Size & Forecast 2020-2030, USD Million
  • Traditional Insulins- Market Size & Forecast 2020-2030, USD Million
    • Novolin/ Actrapid/Insulatard- Market Size & Forecast 2020-2030, USD Million
    • Humulin- Market Size & Forecast 2020-2030, USD Million
    • Insuman- Market Size & Forecast 2020-2030, USD Million
  • Biosimilar Insulins- Market Size & Forecast 2020-2030, USD Million
    • Insulin Glargine Biosimilars- Market Size & Forecast 2020-2030, USD Million
    • Human Insulin Biosimilars- Market Size & Forecast 2020-2030, USD Million
• By Oral Anti-Diabetic Drugs
  • Biguanides- Market Size & Forecast 2020-2030, USD Million
    • Metformin- Market Size & Forecast 2020-2030, USD Million
  • Alpha-Glucosidase Inhibitors- Market Size & Forecast 2020-2030, USD Million
  • Dopamine D2 receptor agonist- Market Size & Forecast 2020-2030, USD Million
    • Bromocriptin- Market Size & Forecast 2020-2030, USD Million
  • SGLT-2 Inhibitors- Market Size & Forecast 2020-2030, USD Million
    • Invokana (Canagliflozin)- Market Size & Forecast 2020-2030, USD Million
    • Jardiance (Empagliflozin)- Market Size & Forecast 2020-2030, USD Million
    • Farxiga/Forxiga (Dapagliflozin)- Market Size & Forecast 2020-2030, USD Million
    • Suglat (Ipragliflozin)- Market Size & Forecast 2020-2030, USD Million
  • DPP-4 Inhibitors- Market Size & Forecast 2020-2030, USD Million
    • Onglyza (Saxagliptin)- Market Size & Forecast 2020-2030, USD Million
    • Tradjenta (Linagliptin)- Market Size & Forecast 2020-2030, USD Million
    • Vipidia/Nesina(Alogliptin)- Market Size & Forecast 2020-2030, USD Million
    • Galvus (Vildagliptin)- Market Size & Forecast 2020-2030, USD Million
  • Sulfonylureas- Market Size & Forecast 2020-2030, USD Million
  • Meglitinides- Market Size & Forecast 2020-2030, USD Million
• By Non-Insulin Injection Drugs
  • GLP-1 Receptor Agonists- Market Size & Forecast 2020-2030, USD Million
    • Victoza (Liraglutide)- Market Size & Forecast 2020-2030, USD Million
    • Byetta (Exenatide)- Market Size & Forecast 2020-2030, USD Million
    • Bydureon (Exenatide)- Market Size & Forecast 2020-2030, USD Million
    • Trulicity (Dulaglutide)- Market Size & Forecast 2020-2030, USD Million
    • Lyxumia (Lixisenatide)- Market Size & Forecast 2020-2030, USD Million
  • Amylin Analogue- Market Size & Forecast 2020-2030, USD Million
    • Symlin (Pramlintide)- Market Size & Forecast 2020-2030, USD Million
• By Combination Drugs
  • Insulin Combinations- Market Size & Forecast 2020-2030, USD Million
    • NovoMix (Biphasic Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million
    • Ryzodeg (Insulin Degludec and Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million
    • Xultophy (Insulin Degludec and Liraglutide)- Market Size & Forecast 2020-2030, USD Million
  • Oral Combinations- Market Size & Forecast 2020-2030, USD Million
    • Janumet (Sitagliptin and Metformin)- Market Size & Forecast 2020-2030, USD Million
• By Distribution Channel
  • Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Clinics and Diabetes Centers- Market Size & Forecast 2020-2030, USD Million
• By Region
  • Northern
  • Central
  • Southern
  • Eastern
  • Western

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including -   Novo Nordisk A/S, Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck and Co., AstraZeneca, Julphar, Bristol Myers Squibb, Novartis, Sanofi Aventis, and others

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/saudi-arabia-diabetes-drug-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release